Recent Advances in the Molecular Genetics of Sarcomas
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (30 November 2025) | Viewed by 1365
Special Issue Editor
Special Issue Information
Dear Colleagues,
Sarcomas are a heterogeneous group of tumors that arise in bone and soft tissue, encompassing a large spectrum of entities with distinct histogenesis and unique clinical and histomorphological characteristics. With the advancement of molecular genetic studies in recent years, these tumors have been shown to possess unique molecular characteristics that enhance the classification, diagnosis, and treatment of these rare tumors, particularly improving the reservoir for targeted therapies. When overlapping molecular events are identified in seemingly distinct tumor types, questions regarding the optimum classification of these tumors arise, along with questions concerning their genetic makeup. In this Special Issue, we welcome papers that illustrate novel molecular genetic findings with regard to sarcomas, in terms of the diagnosis, classification, and treatment of these tumors. Papers/reviews focusing on new paradigms in classification and treatment are especially welcome.
Dr. Wei Jiang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sarcoma, bone and soft tissue
- molecular genetics
- molecular pathology
- classification
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
